Table 5. Effect of LAB-fermented MLE on serum lipid profiles in loperamide-induced constipated rats.
| Groups1) | ||||
|---|---|---|---|---|
| N | C | MLEL | MLEH | |
| Triglyceride (mg/dL) | 94.21±8.013)a4) | 96.43±11.89a | 80.36±8.84ab | 75.21±10.22b |
| Total cholesterol (mg/dL) | 88.21±10.65a | 91.01±12.74a | 74.01±9.78b | 70.17±7.12b |
| HDL-cholesterol (mg/dL) | 35.26±1.02b | 31.13±4.21b | 45.39±5.01a | 50.29±2.01a |
| LDL-cholesterol (mg/dL) | 71.79±5.26a | 79.17±4.18a | 44.69±5.01b | 34.92±2.01b |
1)N, normal group; C, loperamide treated group; MLEL, loperamide and LAB-fermeneted MLE 300 mg/kg b.w. treated group; and MLEH, loperamide and LAB-fermeneted MLE 600 mg/kg b.w. treated group.
2)Mean±S.E. (n=8).
3)Values with different superscripts in the same row are significantly different (p<0.05) between groups as determined via Tukey's test.